Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
about
A phase II study of paclitaxel-ifosfamide-cisplatin combination in advanced nonsmall cell lung carcinoma.Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376)Clinical studies in non-small cell lung cancer: the CALGB experience.Paclitaxel: a hope for advanced non-small cell lung cancer?
P2860
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@ast
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@en
type
label
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@ast
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@en
prefLabel
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@ast
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@en
P2093
P1433
P1476
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study.
@en
P2093
B L Samuels
G A Masters
H M Golomb
L C Drinkard
P C Hoffman
S A Krauss
P304
P356
10.1093/OXFORDJOURNALS.ANNONC.A010578
P577
1996-03-01T00:00:00Z